Pages that link to "Q130278940"
Jump to navigation
Jump to search
The following pages link to Igle J. de Jong (Q130278940):
Displaying 50 items.
- β3-Adrenoceptor-mediated relaxation of rat and human urinary bladder: roles of BKCa channels and Rho kinase (Q35762174) (← links)
- Impact of fasting on (18)F-fluorocholine gastrointestinal uptake and detection of lymph node metastases in patients with prostate cancer (Q36437349) (← links)
- LHRH agonists in prostate cancer: frequency of treatment, serum testosterone measurement and castrate level: consensus opinion from a roundtable discussion (Q36828962) (← links)
- EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study (Q37377297) (← links)
- High risk bladder cancer: current management and survival (Q37873975) (← links)
- Multimerization improves targeting of peptide radio-pharmaceuticals (Q37999918) (← links)
- Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review (Q38035794) (← links)
- An update of radiolabeled bombesin analogs for gastrin-releasing peptide receptor targeting (Q38083714) (← links)
- EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study (Q38618544) (← links)
- (18)F-DCFPyL PET/CT in the detection of prostate cancer at 60 and 120 minutes ; detection rate, image quality, activity kinetics and biodistribution (Q38815886) (← links)
- CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy (Q39284720) (← links)
- Evaluation of a technetium-99m labeled bombesin homodimer for GRPR imaging in prostate cancer (Q39308072) (← links)
- PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy (Q39357182) (← links)
- Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer (Q39470254) (← links)
- (99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model (Q39519531) (← links)
- Does computed tomography or positron emission tomography/computed tomography contribute to detection of small focal cancers in the prostate? (Q39885880) (← links)
- Fine needle aspiration using improved agar microbiopsy is highly concordant with renal mass final diagnosis and subclassification (Q39937962) (← links)
- Compliance with biopsy recommendations of a prostate cancer risk calculator. (Q39999541) (← links)
- Prospective validation of a risk calculator which calculates the probability of a positive prostate biopsy in a contemporary clinical cohort. (Q40025669) (← links)
- Prognostic parameters for response to enzalutamide after docetaxel and abiraterone treatment in metastatic castration-resistant prostate cancer patients; a possible time relation (Q41339007) (← links)
- Detection of local, regional, and distant recurrence in patients with psa relapse after external-beam radiotherapy using (11)C-choline positron emission tomography (Q43270709) (← links)
- 89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment. (Q44151994) (← links)
- Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET. (Q44350528) (← links)
- Sleep-Related Painful Erections-A Case Series of 24 Patients Regarding Diagnostics and Treatment Options (Q44501285) (← links)
- Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer (Q45384878) (← links)
- In vivo uptake of [11C]choline does not correlate with cell proliferation in human prostate cancer (Q46375907) (← links)
- Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin beta-subunit and pituitary gonadal hormones (Q46623758) (← links)
- Treatment and outcome in muscle invasive bladder cancer: a population-based survey. (Q46672274) (← links)
- (99m)Tc-HDP bone scintigraphy and (18)F-sodiumfluoride PET/CT in primary staging of patients with prostate cancer. (Q46780712) (← links)
- Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer (Q46874421) (← links)
- Sleep-Related Painful Erections: A Meta-Analysis on the Pathophysiology and Risks and Benefits of Medical Treatments (Q47656835) (← links)
- Application of (99m)Technetium-HYNIC(tricine/TPPTS)-Aca-Bombesin(7-14) SPECT/CT in prostate cancer patients: a first-in-man study (Q47923926) (← links)
- WNT2 locus is involved in genetic susceptibility of Peyronie's disease (Q49162042) (← links)
- Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy (Q50730617) (← links)
- 89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma (Q51194066) (← links)
- Cediranib monotherapy in patients with advanced renal cell carcinoma: results of a randomised phase II study (Q51435694) (← links)
- Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer (Q51737133) (← links)
- Precision-cut human kidney slices as a model to elucidate the process of renal fibrosis. (Q52893848) (← links)
- Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment. (Q54379716) (← links)
- [Treating 'healthy' men who have localised cancer of the prostate]. (Q54755590) (← links)
- Verteporfin as a Medical Treatment in Peyronie's Disease (Q57067757) (← links)
- Molecular Imaging of Prostate Cancer: Tapping into the Opportunities (Q57779429) (← links)
- Re: Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer. Eur Urol 2011;59:572–83 (Q57780581) (← links)
- Een patiënt met een grote niertumor: niet altijd voor de uroloog (Q59520846) (← links)
- Persistent Müllerian duct syndrome (Q73134339) (← links)
- Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer (Q87091194) (← links)
- CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model (Q87652766) (← links)
- Priapism Throughout the Ages (Q88576537) (← links)
- Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era (Q89496327) (← links)
- [Priapism is an emergency] (Q90439838) (← links)